CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 263 filers reported holding CYTOKINETICS INC in Q1 2023. The put-call ratio across all filers is 0.99 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $382,097 | -33.2% | 12,970 | -26.0% | 0.00% | 0.0% |
| Q2 2023 | $572,090 | -14.6% | 17,538 | -7.9% | 0.00% | 0.0% |
| Q1 2023 | $670,017 | -25.6% | 19,040 | -3.1% | 0.00% | -50.0% |
| Q4 2022 | $900,271 | -7.9% | 19,648 | -2.6% | 0.00% | 0.0% |
| Q3 2022 | $977,000 | -1.7% | 20,171 | -20.2% | 0.00% | 0.0% |
| Q2 2022 | $994,000 | +42.0% | 25,291 | +33.0% | 0.00% | +100.0% |
| Q1 2022 | $700,000 | -19.9% | 19,017 | -0.9% | 0.00% | 0.0% |
| Q4 2021 | $874,000 | +26.3% | 19,182 | -0.9% | 0.00% | 0.0% |
| Q3 2021 | $692,000 | +1997.0% | 19,351 | +1047.1% | 0.00% | – |
| Q2 2021 | $33,000 | +106.2% | 1,687 | +144.8% | 0.00% | – |
| Q1 2021 | $16,000 | +14.3% | 689 | 0.0% | 0.00% | – |
| Q4 2020 | $14,000 | +40.0% | 689 | +53.8% | 0.00% | – |
| Q3 2020 | $10,000 | +150.0% | 448 | +135.8% | 0.00% | – |
| Q2 2020 | $4,000 | +100.0% | 190 | 0.0% | 0.00% | – |
| Q1 2020 | $2,000 | 0.0% | 190 | 0.0% | 0.00% | – |
| Q4 2019 | $2,000 | 0.0% | 190 | 0.0% | 0.00% | – |
| Q3 2019 | $2,000 | 0.0% | 190 | 0.0% | 0.00% | – |
| Q2 2019 | $2,000 | 0.0% | 190 | 0.0% | 0.00% | – |
| Q1 2019 | $2,000 | +100.0% | 190 | 0.0% | 0.00% | – |
| Q4 2018 | $1,000 | 0.0% | 190 | +31.9% | 0.00% | – |
| Q3 2018 | $1,000 | 0.0% | 144 | +94.6% | 0.00% | – |
| Q3 2017 | $1,000 | 0.0% | 74 | 0.0% | 0.00% | – |
| Q2 2017 | $1,000 | 0.0% | 74 | 0.0% | 0.00% | – |
| Q1 2017 | $1,000 | -95.8% | 74 | -96.8% | 0.00% | – |
| Q4 2015 | $24,000 | +33.3% | 2,284 | -12.9% | 0.00% | – |
| Q3 2015 | $18,000 | -25.0% | 2,621 | -26.2% | 0.00% | – |
| Q2 2015 | $24,000 | -4.0% | 3,550 | -2.2% | 0.00% | – |
| Q1 2015 | $25,000 | -16.7% | 3,629 | -1.7% | 0.00% | – |
| Q4 2014 | $30,000 | +114.3% | 3,693 | -7.5% | 0.00% | – |
| Q3 2014 | $14,000 | -26.3% | 3,993 | +0.5% | 0.00% | – |
| Q2 2014 | $19,000 | -50.0% | 3,975 | 0.0% | 0.00% | – |
| Q1 2014 | $38,000 | +58.3% | 3,975 | +7.8% | 0.00% | – |
| Q4 2013 | $24,000 | -14.3% | 3,686 | 0.0% | 0.00% | – |
| Q3 2013 | $28,000 | – | 3,686 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $6,580,834 | 7.72% |
| Finepoint Capital LP | 431,693 | $12,717,676 | 6.33% |
| Saturn V Capital Management LP | 495,168 | $14,587,649 | 6.11% |
| Logos Global Management LP | 1,250,000 | $36,825,000 | 4.91% |
| DAFNA Capital Management LLC | 479,538 | $14,127,189 | 4.39% |
| PFM Health Sciences, LP | 2,399,545 | $70,690,596 | 3.33% |
| Boxer Capital, LLC | 2,100,000 | $61,866,000 | 3.29% |
| Integral Health Asset Management, LLC | 800,000 | $23,568,000 | 3.26% |
| GREAT POINT PARTNERS LLC | 600,000 | $17,676,000 | 3.22% |
| Nicholas Investment Partners, LP | 942,137 | $27,755,356 | 2.07% |